| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/22/2007 | WO2007032376A1 SECRETORY IgA AND IgG ANTIBODIES-INDUCING AGENT |
| 03/22/2007 | WO2007032004A1 Use of amine-borane compounds as anti-microbial agents |
| 03/22/2007 | WO2007031791A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/22/2007 | WO2007031726A1 Purine derivatives having immuno-modulating properties |
| 03/22/2007 | WO2007031574A2 Therapeutic use of outer shigella protein f (os pf) |
| 03/22/2007 | WO2007031334A2 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 03/22/2007 | WO2007008780A3 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 03/22/2007 | WO2006123969A3 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
| 03/22/2007 | WO2006121713A3 Delivery of tigecycline in the presence of heparin |
| 03/22/2007 | WO2006121466A3 Hcv inhibitors |
| 03/22/2007 | WO2006115353A9 A novel hydroxamic acid derivative as peptide deformylase inhibitor and manufacturing method thereof |
| 03/22/2007 | WO2006030217A3 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| 03/22/2007 | WO2006002909A3 Sphingolipids against pathological processes in lipid rafts |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070066684 Preparations composed of specific phorbol derivative and an agent having another anti-HIV effect different in mechanism of action with that of the phorbol derivative; therefore, preparations can exert plural antiviral effects through different mechanisms of action to provide strong antiviral effect |
| 03/22/2007 | US20070066681 Pharmaceutical composition for treating fatty liver or hepatic disease |
| 03/22/2007 | US20070066654 Using4,4-dimethyl-6-methyleme-2-cyclohexene-1-one |
| 03/22/2007 | US20070066639 Oxime substituted imidazoquinolines |
| 03/22/2007 | US20070066622 2-(3-Phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066547 Ligands |
| 03/22/2007 | US20070066544 3-Decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065509 Comprises ciprofloxacin and hydroxypropylmethylcellulose for improving visocisty |
| 03/22/2007 | US20070065485 Therapeutic delivery of carbon monoxide |
| 03/22/2007 | US20070065458 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622587A1 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 03/22/2007 | CA2622508A1 Medicament for the prevention and treatment of influenza |
| 03/22/2007 | CA2622242A1 Inhibition of viral gene expression using small interfering rna |
| 03/22/2007 | CA2621939A1 Therapeutic use of outer shigella protein f (os pf) |
| 03/22/2007 | CA2621364A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764099A2 Diaminoalcohol derivatives for the treatment of Alzheimer, malaria, HIV |
| 03/21/2007 | EP1764098A1 Diaminoalcohols derivatives for the treatment of Alzheimer, malaria, HIV |
| 03/21/2007 | EP1763531A1 Hepatitis c inhibitor peptide analogs |
| 03/21/2007 | EP1763355A1 Use of composition comrising d-mannoheptulose and/or perseitol for the treatment and prevention of diseases linked to a modification of the innate immunity |
| 03/21/2007 | EP1763348A1 Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors |
| 03/21/2007 | EP1763342A2 Sphingolipids against pathological processes in lipid rafts |
| 03/21/2007 | EP1763341A2 Compositions and methods for treating pathological infections |
| 03/21/2007 | EP1648504B1 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 03/21/2007 | EP1539752B1 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via novel imidazo[4,5-c]quinolin-4-cyano and 1h-imidazo[4,5-c]quinolin-4-carboxamide intermediates |
| 03/21/2007 | EP1515710B1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1448052B1 Anti-pathogenic composition useful in blood preservation |
| 03/21/2007 | EP1401826B1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 03/21/2007 | EP1383534B1 Chalamydia vaccine based on blebs |
| 03/21/2007 | EP1345943B1 Inhibitors of papilloma virus |
| 03/21/2007 | EP1339415B1 composition of multipurpose high functional alkaline solution composition, preparation thereof, and use as nonspecific immunostimulator |
| 03/21/2007 | EP1313771B1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 03/21/2007 | EP1242059B1 Novel prodrugs for antimicrobial amidines |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | EP1133298B1 Compositions comprising cefuroxime axetil |
| 03/21/2007 | EP1126876B1 Adjuvant systems and vaccines |
| 03/21/2007 | EP1007088B1 Recombinant porcine adenovirus vector |
| 03/21/2007 | CN1934240A Attenuated gram negative bacteria |
| 03/21/2007 | CN1934118A Trihemihydrate, anhydrate and hydrate forms of cefdinir |
| 03/21/2007 | CN1934101A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 03/21/2007 | CN1934093A Pyrimidyl phosphonate antiviral compounds and methods of use |
| 03/21/2007 | CN1934092A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 03/21/2007 | CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 03/21/2007 | CN1933813A Compositions and methods for delivery of biologically active agents |
| 03/21/2007 | CN1931859A New fused imidazole derivative |
| 03/21/2007 | CN1931365A Hcv e1e2 vaccine compositions |
| 03/21/2007 | CN1931364A Prepn process of oral vaccine for antagonizing bacterial diseases of aquatic animal |
| 03/21/2007 | CN1931359A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931358A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931356A Chinese medicine for clearing away heat and toxic matter to prevent and treat common cold and the method of preparing herb tea, oral liquid and granule therewith |
| 03/21/2007 | CN1931349A Antiviral eye drop containing zedoary oil |
| 03/21/2007 | CN1931347A Medicine for treating chronic hepatitis and its prepn process and quality control method |
| 03/21/2007 | CN1931331A Chinese medicine composition for treating hepatitis B and its prepn process |
| 03/21/2007 | CN1931313A Chinese herbal medicine digestant for treating lymphoid tuberculosis and cervical lymphadenitis |
| 03/21/2007 | CN1931262A Common cold treating Chinese medicine prepn |
| 03/21/2007 | CN1931259A Process of extracting effective component from papaya |
| 03/21/2007 | CN1931244A Chinese medicine composition for treating urinary infection |
| 03/21/2007 | CN1931239A Chinese medicine prepn for treating hepatitis B |
| 03/21/2007 | CN1931230A Isodon lophanthoides extract and its prepn process and application |
| 03/21/2007 | CN1931209A Application of Qiannianai in preparing medicine for treating chronic viral hepatitis B |
| 03/21/2007 | CN1931208A Application of common goldenrod herb in preparing medicine for preventing and treating H5N1 bird flu and influenza |
| 03/21/2007 | CN1931190A Toad skin extract and its medicine prepn and their prepn |
| 03/21/2007 | CN1931175A Medicine composition for preventing and treating farm animal's respiratory tract and digestive tract diseases |
| 03/21/2007 | CN1931170A Gatifloxacin ear drop and its prepn process |
| 03/21/2007 | CN1931165A Nanometer antifungal econazole nitrate emulsion medicine and its prepn process |
| 03/21/2007 | CN1931164A Nanometer miconazole nitrate emulsion medicine and its prepn process |
| 03/21/2007 | CN1931163A Nanometer clotrimazole emulsion medicine and its prepn process |
| 03/21/2007 | CN1931162A Prduction process and application of ornidazole |
| 03/21/2007 | CN1931155A Antibiotic medicine for treating bacterial infection of farm animal and aquatic animal |
| 03/21/2007 | CN1931151A AIDS treating medicine composition and its prepn process and use |
| 03/21/2007 | CN1931148A Prepn process of levofloxacin lactate oral film |
| 03/21/2007 | CN1931144A Entecavir effervescent tablet and its prepn process |
| 03/21/2007 | CN1931138A Entecavir granule and its prepn process |
| 03/21/2007 | CN1931137A Masked berberine hydrochloride micro pill and its prepn |